Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Clinuvel Pharmaceuticals is a global biopharmaceutical company headquartered in Australia. The firm focuses on the development of innovative drugs for rare skin disorders. Through the application of specialized therapies, Clinuvel improves the quality of life for patients across the globe.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Clinuvel Pharmaceuticals is scheduled to report its next quarterly earnings on 08/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Clinuvel Pharmaceuticals last reported quarterly earnings on 2/25/2026 (Q4 2025). Earnings per share (EPS) came in at 0.21 AUD.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.